BRIEFING NOTES

Details

MARKET WITHDRAWAL OF INTRAVENOUS RANITIDINE (March 2022)

GEDEFO-SEFH TECHNICAL NOTICE ON THE CHANGE IN THE DOSE EXPRESSION OF HYDROCORTISONE AND EQUIVALENCE IN INTRATHECAL PREPARATIONS (June 2022)